Kitazato Corporation (368A) Shareholders
Market cap
¥53.7B
P/E ratio
13.6x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
大株主
| （単位：千株） | 2025/03 | 2026/03 |
|---|---|---|
| 北里商事 | 23,400 58.5% | 22,300 55.75% |
| 日本マスタートラスト信託銀行 | 2,749 6.87% | |
| 日本カストディ銀行 | 2,043.2 5.11% | |
| 野村信託銀行 | 1,267.3 3.17% | |
| 井上 太綬 | 1,200 3% | |
| GOVERNMENT OF NORWAY | 1,150 2.88% | |
| HSBC BANK PLC A/C M AND G VALUE PARTNERS CHINA EQUITY FUND | 560.128 1.4% | |
| BBH FOR BBHTSIL NEUBERGER BERMAN INVESTMENT FUNDS PLC-NEUBERGER BERMAN JAPAN EQUITY ENGAGEMENT FUND | 510 1.28% | |
| MSIP CLIENT SECURITIES | 447.611 1.12% | |
| STATE STREET BANK AND TRUST COMPANY | 402.057 1.01% | |
| 井上太綬 | 14,000 35% | |
| H＆Fパートナーズ | 1,800 4.5% | |
| ナレツジイラア | 800 2% | |
| 計 | 40,000 100% | 32,629.296 81.57% |